Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DB25FJ1XS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,830
Award facts
- Contract value 100% obligated
- $11,830.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injection units. This non-set-aside, firm fixed price delivery order was competitively awarded on May 30, 2025, with an ultimate completion date of June 23, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle extending through December 2026 that enables comprehensive global pharmaceutical support to military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare systems. The company maintains an extensive portfolio of federal contract awards involving brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. SKYRIZI is a biologic treatment used in dermatology, and this delivery order represents a routine procurement fulfillment under the company's master IDC with the DLA, demonstrating its ongoing capability to supply specialized pharmaceutical products to support federal healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FJ1XS?
SPE2DB25FJ1XS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FJ1XS worth?
The government has obligated $11,830 on SPE2DB25FJ1XS.
Is contract SPE2DB25FJ1XS an order under another contract?
Yes. SPE2DB25FJ1XS is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ1XS competed?
The extent of competition for SPE2DB25FJ1XS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award